ArticleInternational journal of toxicology
Preclinical Safety Evaluation of BB106, a Novel Ketamine-Sulfobutylether-Beta-Cyclodextrin Salt, Following Subcutaneous Administration in Rats and Göttingen Minipigs.
Yuval Ramot et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.